0001104659-20-122958.txt : 20201109 0001104659-20-122958.hdr.sgml : 20201109 20201109142029 ACCESSION NUMBER: 0001104659-20-122958 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20201109 DATE AS OF CHANGE: 20201109 EFFECTIVENESS DATE: 20201109 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PRESBYOPIA THERAPIES, INC. CENTRAL INDEX KEY: 0001678518 IRS NUMBER: 901015551 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-380075 FILM NUMBER: 201297146 BUSINESS ADDRESS: STREET 1: 915 OCEAN BLVD. CITY: CORONADO STATE: CA ZIP: 92118 BUSINESS PHONE: 619-890-5125 MAIL ADDRESS: STREET 1: 915 OCEAN BLVD. CITY: CORONADO STATE: CA ZIP: 92118 FORMER COMPANY: FORMER CONFORMED NAME: PRESBYOPIA THERAPIES, LLC DATE OF NAME CHANGE: 20160629 D 1 primary_doc.xml X0708 D LIVE 0001678518 PRESBYOPIA THERAPIES, INC. 915 OCEAN BOULEVARD CORONADO CA CALIFORNIA 92118 619-890-5125 DELAWARE Presbyopia Therapies, LLC PRESBYOPIA THERAPIES, LLC Corporation true James W. McCollum 915 Ocean Boulevard Coronado CA CALIFORNIA 92118 Executive Officer Director Executive Officer and Director Gerald Horn 1150 Heather Road Deerfield IL ILLINOIS 60015 Executive Officer Director Executive Officer and Director Mark Lester 73 Martin Road Wellesley MA MASSACHUSETTS 02481 Director Director Pharmaceuticals Decline to Disclose 06b false 2020-10-30 true true true true false 0 68250000 1751193 66498807 Total Amount Sold includes $251,193 which is attributable to the conversion of Convertible Notes to Series A Preferred Stock false 30 0 0 0 false PRESBYOPIA THERAPIES, INC. /s/ James W. McCollum James W. McCollum President 2020-11-09